Depression drug study halted early – what we know
NCT ID NCT06618118
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 34 times
Summary
This study tested a new medicine called fosigotifator for adults with major depression. About 20 people were planned to take either the drug or a placebo to see if it was safe and helped symptoms. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CenExel CNR /ID# 265866
Sherman Oaks, California, 91403, United States
-
CenExel iResearch, LLC /ID# 265886
Decatur, Georgia, 30030-3440, United States
-
Clinical Neuroscience Solutions - Orlando - East South Street /ID# 265060
Orlando, Florida, 32801, United States
-
Northwest Clinical Research Center /ID# 265057
Bellevue, Washington, 98007, United States
Conditions
Explore the condition pages connected to this study.